| | | | | - | - | | | |   
                     
| | - | | - | ' '   |     /

  -
  ? 
  ,  
  , ,
  , ,
    ......
   
 
  -.
 
  ...
  
    - 
 
   
  .   
  
  • -
  • BMI
       
     
    ,

    ' - , , , -; , , -.

    , . , , - , . - , , : Hades Percephone - .

    , , , .

    , ( Rummān ) . : . , , - . בּ'- , , . , , .

    , , Imhotep 4,600 ,
    , " " , . , . ,
    Punica granatum, , , , , , . -80% -20% . -85% -10% , C, , . , estrone, coumestrol, (isoflavones), -genistein -daidzein, . 18 , פּוּ (punicic acid).

    , , . , , "", 1975 -1999 38 , . -90 , 1999 138 , , ' , " . ' , " וֹ -Rimonest 2000 Punisyn Pharmceuticalsl, .

    ' 2001 Atherosclerosis (50 1.5 ) - , ACE angiotensin converting enzyme 36%, 5% .

    -LDL . , -LDL, "" .

    , paraoxonase, . , .

    2006 -Atherosclerosis , (oxidative stress) . 10 -10 type 2, 3 50 . , , -56% ( ) -141%. - , .

    . 19
    (
    carotid) . 19 , . -9% , . . " 2005 45 (), . 3 -250 , .

    : , . , . , , , .

    . (וּ) , -. -nude mice : , . , , , PSA , .

    2 nude, DMBA, : MAPK mitogen-activated protein kinase, . , NFkB . , 16 , -3 .

    ((In-vitro, -Matrigel, , . (angiogenesis) .

    , 46 , , , PSA . PSA 0.2 5.0 , -7 Gleason. 2006 Clinical Cancer Research UCLA, ' , . , -250 .

    PSA, PSA 15 , -54 . LnCAP . , 12% LnCAP , -17% LnCAP, . .

    "" , "herbal medicine", , ? Andrew Vickers, ( ) ) Sloan-Kettering -, " בּוֹ , , , , , ".

    " , , , , , .

    , , .

    ' -


    19/04/2007

     
       


    , , " , "
    , " " .

    / , , , / / . .
    / , , , / , / . .

    ,
    / " .




    | |
    | | | | | | |
    | | | |
    | | | |